MeiraGTx Holdings plc (MGTX)
NASDAQ: MGTX · Real-Time Price · USD
7.46
-0.06 (-0.80%)
Feb 11, 2026, 4:00 PM EST - Market closed
MeiraGTx Holdings Market Cap
MeiraGTx Holdings has a market cap or net worth of $600.46 million as of February 12, 2026. Its market cap has increased by 24.32% in one year.
Market Cap
600.46M
Enterprise Value
673.68M
1-Year Change
24.32%
Ranking
Category
Stock Price
$7.46
Market Cap Chart
Since June 8, 2018, MeiraGTx Holdings's market cap has increased from $407.76M to $600.46M, an increase of 47.26%. That is a compound annual growth rate of 5.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 605.29M | -5.41% |
| Dec 31, 2025 | 639.90M | 34.45% |
| Dec 31, 2024 | 475.95M | 6.61% |
| Dec 29, 2023 | 446.45M | 41.25% |
| Dec 30, 2022 | 316.07M | -70.05% |
| Dec 31, 2021 | 1.06B | 60.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| enGene Holdings | 638.36M |
| Rigel Pharmaceuticals | 628.40M |
| Alpha Tau Medical | 627.54M |
| LB Pharmaceuticals | 612.74M |
| CorMedix | 605.89M |
| Prime Medicine | 605.47M |
| ProKidney | 604.68M |
| Design Therapeutics | 582.74M |